Edgewise Therapeutics, Inc. (EWTX) stock
EWTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$45.93+0.11 (+0.24%)
Close on Nov 13, 2026Market cap $4.99BP/E 5.6Yield –
Edgewise Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Edgewise Therapeutics's enterprise value was $5.05B on Nov 11, 2026, against $2.71B a year earlier. Over the last 5 years it ranged from $275.27M to $5.05B, with a median of $1.31B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.05B | +96.0% |
| 2025 | Dec 31, 2025 | $2.58B | +4.1% |
| 2024 | Dec 31, 2024 | $2.48B | +274.4% |
| 2023 | Dec 29, 2023 | $661.31M | +45.2% |
| 2022 | Dec 30, 2022 | $455.35M | -38.7% |
| 2021 | Dec 31, 2021 | $742.67M | – |
See a number that looks wrong?